GJC2 and Alzheimer disease: Furthermore, we demonstrate decreased immunoreactivity of Cx47, for the first time in a mouse model of AD, indicating disruption of A/O GJs, together with depletion in oligodendrocyte precursor cells (OPCs) and mature oligodendrocytes, possibly contributing to neuronal degeneration and AD progression.